1. Carbonare LD, Matte’ A, Valenti MT, Siciliano A, Mori A, Schweiger V, Zampieri G, Perbellini L, De Franceschi L (2015) Hypoxia-reperfusion affects osteogenic lineage and promotes sickle cell bone disease. Blood, J Am Soc Hematol 126:2320–2328
2. Chen RM, Wu GJ, Chang HC, Chen JT, Chen TF, Lin YL, Chen TL (2005) 2, 6-Diisopropylphenol Protects Osteoblasts from Oxidative Stress-Induced Apoptosis through Suppression of Caspase-3 Activation. Ann N Y Acad Sci 1042:448–459
3. Collard CD, Gelman S (2001) Pathophysiology, clinical manifestations, and prevention of ischemia-reperfusion injury. J Am Soc Anesthesiologists 94:1133–1138
4. de Vries DK, Kortekaas KA, Tsikas D, Wijermars LG, van Noorden CJ, Suchy M-T, Cobbaert CM, Klautz RJ, Schaapherder AF, Lindeman JH (2013) Oxidative damage in clinical ischemia/reperfusion injury: a reappraisal. Antioxid Redox Signal 19:535–545
5. Domokos G (2017) The Hypoxia-Reoxygenation Injury Model. In Jing Z and Chi Z (eds) Hypoxia and Human Diseases. IntechOpen, Rijeka, pp. Ch. 3. https://www.intechopen.com/chapters/52510